Literature DB >> 2291163

Pseudomembranous colitis: how useful is endoscopy?

J M Bergstein1, A Kramer, D H Wittman, C Aprahamian, E J Quebbeman.   

Abstract

Clostridium difficile colitis may be diagnosed either by endoscopy or by laboratory tests. To determine the role of endoscopy, we reviewed 59 cases of confirmed C. difficile colitis. In all patients, the etiology was confirmed by stool tests. Twenty-nine underwent lower gastrointestinal endoscopy. In 16 (55%) there was endoscopic confirmation of pseudomembranes while 4 (14%) had only nonspecific colitis. There was no apparent difference in the rate of detection of pseudomembranes between rigid sigmoidoscopy (57%), flexible sigmoidoscopy (50%), and colonoscopy (50%). Vancomycin and metronidazole were equally effective therapy but treatment with vancomycin cost more than 250 times that for metronidazole. There were no patients in whom the diagnosis was made by endoscopy alone. Endoscopy was costly and insensitive, while noninvasive stool tests were cheap and accurate. We conclude that endoscopy should be relegated to a secondary role in the workup of antibiotic-associated diarrhea.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291163     DOI: 10.1007/bf00316796

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Evaluation of a commercial kit for the routine detection of Clostridium difficile cytotoxin by tissue culture.

Authors:  T C Wu; S M Gersch
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

2.  Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination.

Authors:  F J Tedesco
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

3.  Treatment of Clostridium difficile colitis.

Authors:  J G Bartlett
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

4.  Antibiotic-associated pseudomembranous colitis.

Authors:  N M Amin
Journal:  Am Fam Physician       Date:  1985-05       Impact factor: 3.292

5.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

6.  Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.

Authors:  M T Kelly; S G Champagne; C H Sherlock; M A Noble; H J Freeman; J A Smith
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

7.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

8.  Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

Authors:  D G Teasley; D N Gerding; M M Olson; L R Peterson; R L Gebhard; M J Schwartz; J T Lee
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

9.  Latex particle agglutination for detecting and identifying Clostridium difficile.

Authors:  R A Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

10.  Clostridium difficile-associated diarrhea follows perioperative prophylaxis with cefoxitin.

Authors:  B S Block; L J Mercer; M A Ismail; A H Moawad
Journal:  Am J Obstet Gynecol       Date:  1985-12-15       Impact factor: 8.661

View more
  8 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 2.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

3.  The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease.

Authors:  T Berdichevski; N Keller; G Rahav; S Bar-Meir; R Eliakim; S Ben-Horin
Journal:  Infection       Date:  2013-05-26       Impact factor: 3.553

4.  Successful treatment with rifampin for fulminant antibiotics-associated colitis in a patient with non-Hodgkin's lymphoma.

Authors:  Kenichi Nomura; Yosuke Matsumoto; Naohisa Yoshida; Sawako Taji; Naoki Wakabayashi; Shoji Mitsufuji; Shigeo Horiike; Masuji Morita; Takeshi Okanoue; Masafumi Taniwaki
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

5.  Indications and Relative Utility of Lower Endoscopy in the Management of Clostridium difficile Infection.

Authors:  Nora E Burkart; Mary R Kwaan; Christopher Shepela; Robert D Madoff; Yan Wang; David A Rothenberger; Genevieve B Melton
Journal:  Gastroenterol Res Pract       Date:  2011-10-17       Impact factor: 2.260

6.  Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile.

Authors:  Hyun Joo Song; Ki-Nam Shim; Sung-Ae Jung; Hee Jung Choi; Mi Ae Lee; Kum Hei Ryu; Seong-Eun Kim; Kwon Yoo
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 2.884

7.  Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report.

Authors:  Bing-Jie Shen; Shih-Chiang Lin; Pei-Wei Shueng; Yueh-Hung Chou; Li-Ming Tseng; Chen-Hsi Hsieh
Journal:  Onco Targets Ther       Date:  2013-01-17       Impact factor: 4.147

Review 8.  Severe acute diarrhea.

Authors:  Julia I Gore; Christina Surawicz
Journal:  Gastroenterol Clin North Am       Date:  2003-12       Impact factor: 3.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.